Progress with a difficult infection.
Microbiology Department, Old Medical School, Leeds General Infirmary and University of Leeds, Leeds LS1 3EX, UK. mark.wilcox@leedsth.nhs.uk
Mark H
MH
Wilcox
D000617:Aminoglycosides / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016360:Clostridioides difficile / Q000302:isolation & purification*; D003967:Diarrhea / Q000188:drug therapy*; D004761:Enterocolitis, Pseudomembranous / Q000188:drug therapy*; D005260:Female; D000077732:Fidaxomicin; D006801:Humans; D008297:Male; D014640:Vancomycin / Q000627:therapeutic use*
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D014640:Vancomycin; D000077732:Fidaxomicin